Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: Arrevus’s Oral Antibiotic ARV-1801 Receives FDA Orphan Drug Designation as CF Treatment Patients, Supporters Worldwide Recognizing Rare Disease Day 2020 Arrevus’s Oral Antibiotic ARV-1801 Receives FDA Orphan Drug Designation as CF Treatment Feb 21, 2020 07:00 am | Iqra Mumal MSc The U.S. Food and Drug Administration (FDA) has granted its orphan drug designation to ARV-1801 (sodium fusidate tablets), a treatment developed by Arrevus for patients with cystic fibrosis (CF). CF patients frequently develop lung infections due to the accumulation of thick mucus in their lungs, creating an optimal environment for bacterial growth. Such bacterial infections […] The post Arrevus’s Oral Antibiotic ARV-1801 Receives FDA Orphan Drug Designation as CF Treatment appeared first on Cystic Fibrosis News Today. Read More Patients, Supporters Worldwide Recognizing Rare Disease Day 2020 Feb 20, 2020 07:00 am | Mary Chapman An abundance of events are afoot around the world to mark Rare Disease Day 2020 on Feb. 29. The activities are focused on heightening awareness about rare diseases and the hundreds of millions of individuals they are thought to affect. Patients, caregivers, and advocates worldwide will sport denim ribbons and zebra stripes, paint their faces, […] The post Patients, Supporters Worldwide Recognizing Rare Disease Day 2020 appeared first on Cystic Fibrosis News Today. Read More   Recent News Majority of Home Nebulizers Used by CF Children Contaminated with Microorganisms, Leading to Exacerbated Symptoms, Study Finds Important Breaking News: I Am Not You Synspira Therapeutics, CF Foundation Agree to Support Development of SNSP003 for Malabsorption Syndromes Trust the Process: Your Hard Work Will Be Worth It in the End Noninvasive XV Technology May Lead to Faster CF Diagnosis and Better Treatment